Literatur
-
1
Anand P, Sundaram C, Jhurani S. et al .
Curcumin and cancer: an “old-age” disease with an “age-old” solution.
Cancer Lett.
2008;
267
133-164
-
2
Babu P V, Liu D.
Green tea catechins and cardiovascular health: an update.
Curr Med Chem.
2008;
15
1840-1850
-
3
Boots A W, Wilms L C, Sweenen E L, Kleinjans J C, Bast A, Haenen G R.
In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers.
Nutrition.
2008;
24
703-710
-
4
Bosscher de K, Berghe van den W, Haegeman G.
The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression.
Endocr Rev.
2003;
24
488-522
-
5
Boswellia serrata. Monograph.
Altern Med Rev.
2008;
13
165-167
-
6
Breslow J L.
n-3 Fatty acids and cardiovascular disease.
Am J Clin Nutr.
2006;
83 (Suppl)
1477S-1482S
-
7
Calabro P, Yeh E T.
Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ.
Subcell Biochem.
2007;
42
63-91
-
8
Calder P.
n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases.
Am J Clin Nutr.
2006;
83 (Suppl)
1505S-1519S
-
9
Charo I F, Ransohoff R M.
The many roles of chemokines and chemokine receptors in inflammation.
New Engl J Med.
2006;
354
610-621
-
10
Casserly I, Topol E.
Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins.
Lancet.
2004;
363
1139-1146
-
11
Devaraj S, Leonard S, Traber M G, Jialal I.
Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome.
Free Radic Biol Med.
2008;
44
1203-1208
-
12
Franceschi C.
Inflammaging as a major characteristic of old people: can it be prevented or cured?.
Nutr Rev.
2007;
65
S173-S176
-
13
Giannoulis-Karantara A, Vlachou A, Polychronopoulou S, Papassotiriou I, Chrousos G Pl.
Melatonin and immunomodulation: connections and potential clinical applications.
Neuroimmunomodulation.
2006;
13
133-144
-
14
Goodfellow J, Bellamy M F, Ramsey M W, Jones C J, Lewis M J.
Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia.
J Am Coll Cardiol.
2000;
35
265-270
-
15
Hämälainen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E.
Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages.
Mediators Inflamm.
2007;
ID 45673
1-10
-
16
Hankey G J, Eikelboom J W.
Aspirin resistance.
Lancet.
2006;
367
606-617
-
17
Hansson G K.
Inflammation, atherosclerosis, and coronary artery disease.
New Engl J Med.
2005;
352
1685-1695
-
18
Harris S G, Padilla J, Koumas L, Ray D, Phipps R P.
Prostaglandins as modulators of immunity.
Tr Immunol.
2002;
23
144-150
-
19
Hatcher H, Planalp R, Cho J. et al .
Curcumin: from ancient medicine to current clinical trials.
Cell Mol Life Sci.
2008;
65
1631-1652
-
20
Jurenka J S.
Therapeutic applications of pomegranate (Punica granatum): a review.
Altern Med Rev.
2008;
13
128-144
-
21
Kaisho T, Tanaka T.
Turning NF-kB and IRFs on and off in DC.
Tr Immunol.
2008;
29
329-336
-
22
Karlsec A, Rettersol L, Laake P. et al .
Anthocyanins inhibit nuclear factor-kB activation in monocytes and reduce olasma concentrations of pro-inflammatory mediators in healthy adults.
J Nutr.
2007;
137
1951-1954
-
23
Lambert C P, Wright N R, Finck B N, Villareal D T.
Exercise but not diet-induced weight loss decreases skeletal muscle inflammatory gene expression in frail obese eldely persons.
J Appl Physiol.
2008;
105
473-478
-
24
Lansky E P, Newman R A.
Punica franatum (pomegranate) and its potential for prevention and treatment of infammation and cancer.
J Ethnopharmacol.
2007;
109
177-206
-
25
Mihm S, Galter D, Dröge W.
Modulation of transcription factor NF-kB activity by intracellular glutathione levels and by variations of the extracellular cysteine supply.
Faseb J.
1995;
9
246-252
-
26
Müller N, Schwarz M J.
A psychoneuroimmunological perspective to Emil Kraepelins dichotomy. Schizophrenia and major depression as inflammatory CNS disorders.
Eur Arch Psychiatry Neurosci.
2008;
258 (Suppl 2)
97-106
-
27
Murakami A, Ashida H, Terao J.
Multitargeted cancer prevention by quercetin.
Cancer Lett.
2008;
269
315-325
-
28
Murias M, Handler N, Erker T. et al .
Resveratrol analogues as selective cyclooxygenase-2 inhibitors: snythesis and structure-activity relationship.
Bioorg Med Chem.
2004;
12
5571-5578
-
29
Pascual G, Glass C K.
Nuclear receptors versus inflammation: mechanisms of transrepression.
Trends Endocrinol Metab.
2006;
17
321-327
-
30
Petersen A MW, Pedersen B K.
The role of IL-6 in mediating the antiinflammatory effects of exercise.
J Physiol Pharmacol.
2006;
57 (Suppl 10)
43-51
-
31
Rainsford K D.
Anti-inflammatory drugs in the 21st century.
Subcell Biochem.
2007;
42
3-27
-
32
Redwine L, Hauger R L, Gillin J C, Irwin M.
Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans.
J Clin Endocrinol Metab.
2000;
85
3597-3603
-
33 Sears B. The antiinflammation zone: reversing the silent epidemic that's destroying our health. Regan Books 2005
-
34
Serhan C N, Brain S D, Buckley C D. et al .
Resolution of inflammation: state of the art, definitions and terms.
Faseb J.
2007;
21
325-332
-
35
Shoelson S E, Lee J, Goldfine A B.
Inflammation and insulin resistance.
J Clin Invest.
2006;
116
1793-1801
-
36
Song Y, Li T Y, van Dam R M, Manson J E, Hu F B.
Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women.
Am J Clin Nutr.
2007;
85
1068-1074
-
37
Takada Y, Bhardwaj A, Potdar P, Aggarwal B B.
Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kB activation, inhibition of cyclooxygenase-2 and cyclin-1, and abrogation of tumor cell proliferation.
Oncogene.
2004;
23
9247-9258
-
38
Tracey K J.
Physiology and immunology of the cholinergic antiinflammatory pathway.
J Clin Invest.
2007;
117
289-296
-
39
Vegeto E, Benedusi V, Maggi A.
Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.
Front Neuroendocrinol.
2008;
29
507-519
-
40
Zhang W J, Frei B.
Alpha-lipoic acid inhibits TNF-alpha induced NF-kB activation and adhesion molecule-1 expression in huma aortic endothelial cells.
Faseb J.
2001;
15
2423-2432
PD Dr. med. Wilfried P. Bieger
Paul-Heyse-Straße 6
80336 München
eMail: wbieger@lab4more.de
